FTC contests support over brain health advertising claims
USA
Jan 26, 2022
The Federal Trade Commission (FTC) pushed back against arguments made by Quincy Bioscience that its advertising claims for Prevagen—a brain health supplement—are supported by “competent and reliable scientific evidence.”
According to the complaint, the defendants represented in national TV ads and elsewhere that Prevagen improves memory within 90 days, reduces memory problems associated with aging, and provides other cognitive benefits, like healthy brain function, a sharper mind, and clearer thinking. What’s more, they claimed to have clinical proof to support their advertising promises.
For further information (in English), click on the Link